Introduction
Cell growth and dierentiation in normal tissues are controlled by a balance of two opposing signaling pathways, namely positive and negative signaling. Although there have been extensive previous eorts dedicated to understanding the positive signaling, studies on the negative signaling are just now accumulating. Recently, a novel family of antiproliferative proteins has been discovered. The family is called the Tob or BTG1 family presently consisting of four members, BTG1, PC3/TIS21/BTG2, Tob, and ANA/BTG3. The BTG1 gene was identi®ed near the breakpoint of chromosomal translocation found in a B-cell chronic lymphocytic leukemia (Rouault et al., 1992) . Whether the BTG1 protein is relevant to the induction of leukemia is not known. It is known, however, that overexpression of BTG1 suppresses growth of NIH3T3 cells. The PC3/TIS21 gene was initially identi®ed as an immediate early gene induced by nerve growth factor stimulation of PC12 cells (Bradbury et al., 1991) and stimulation of Swiss 3T3 cells with tumor promoters (Fletcher et al., 1991) . Its human version was named BTG2 (Rouault et al., 1996) . Expression of PC3 is speci®c to the undifferentiated neuronal cells (Bradbury et al., 1991) , though the function of the gene product remains to be determined. The tob cDNA was cloned by screening an expression library with ErbB-2 protein by means of protein-protein interaction (Matsuda et al., 1996) . The biological signi®cance of the interaction between Tob and ErbB-2 is under investigation. The ANA/BTG3 gene was identi®ed by low stringency screening of a 10-day mouse embryo cDNA library (Guehenneux et al., 1997) or by a PCR-mediated cloning procedure using mRNAs from lymphoma cells (Yoshida et al., 1998) . Again the function of the ANA/BTG3 remains to be established. Apparently, no common function among family members was suggested from the history of their identi®cation. However, these proteins showed strong homology to one another at the amino-terminal 120 amino-acid sequence. The region is called the Tob homology or BTG1 homology domain (Tob/BTG1 homology domain hereafter). Based on the homology, it was speculated that PC3, Tob, and ANA may suppress growth of NIH3T3 cells upon overexpression, as was observed with BTG1 overexpression. Indeed, elevated expression of PC3 (Montagnoli et al., 1996) , Tob (Matsuda et al., 1996) , and ANA (Yoshida et al., 1998) prohibited cell cycle progression through the G1 phase. Furthermore, targeted disruption of both copies of the PC3 gene in embryonic stem cells led to impairment of DNA-damage-induced G2/M arrest and to an increased cell death (Rouault et al., 1996) . These data point out the involvement of the Tob/ BTG1 family proteins in the regulation of cell cycle progression.
CCR4 (CCR, carbon catabolite repression) is a transcription factor required for expression of a number of genes including a gene encoding alcohol dehydrogenase II (Denis, 1984) . Yeast strains carrying deletions at the CCR4 locus show growth defects (Denis and Malver, 1990) . CCR4 forms a complex with multiple proteins (Draper and Denis, 1995; Liu et al., 1997 Liu et al., , 1998 . Caf1 (CCR4-associated factor 1), which is one of the proteins in the complex, directly interacts with CCR4. Caf1 and the other proteins in the CCR4 complex are evolutionarily conserved and therefore may be important in transcription of the gene fundamentally relevant to cell growth and/or differentiation (Draper and Denis, 1995) . In addition, a mutation in the yeast caf1 gene could suppress rad52 mutation (Schild, 1995) , a gene involved both in DNA repair and in mitotic and meiotic recombination (reviewed by Game, 1993) . Although the mechanisms of the suppression remain unclear, the data suggest that Caf1 is also involved in DNA replication and recombination.
To understand the biological importance of the tob/ BTG1 family of anti-proliferative genes, we searched for new family members and identi®ed tob2. Here, we report molecular cloning and characterization of tob2. Our results suggest that Tob2 is involved in cell cycle regulation through the interaction with the CDKassociated Caf1 protein.
Results
Identi®cation and molecular cloning of a novel tob/BTG1 family gene, tob2
In Northern blot hybridization of mRNAs from various human cell lines, the tob probe detected weak signals of mRNA species that were dierent in size from the regular human tob transcript (Matsuda et al., 1996) . The data suggested that there was a gene(s) related to tob. To explore the possibility, we performed RT ± PCR-mediated cDNA cloning. RNAs from FL18 B lymphoma cells that express the variant mRNAs were subjected to reverse-transcription, and PCR ampli®cation using a set of primers that corresponded to the amino acid sequence conserved among Tob/ BTG1 family members. The resulted PCR products (190-bp) were subsequently cloned into the pBluescript plasmid. Nucleotide sequencing of the cloned DNA fragments revealed that most contained a sequence highly homologous to the corresponding region of tob. Thus, we assumed that they represented a novel gene that we tentatively named tob2. To obtain the entire coding region of tob2, we screened a cDNA library generated from mRNAs of Daudi B cells using the cloned DNA as a probe. Two independent positive clones were obtained. Sequence analysis of these clones revealed that they contained an open reading frame of 1035-bp, encoding a polypeptide of 344 amino acids ( Figure 1a) . The calculated molecular weight of the predicted protein was 37 064. Comparison of the amino acid sequence of the newly identi®ed Tob2 protein with those of the other family members are shown in Figure 1b . Apparently, the amino-terminal one-third of the Tob2 protein showed similarity to the Tob/BTG1 homology domain. Tob2 was most closely related (61% homology) to Tob over the entire coding region. Homology between the two proteins was particularly high in the Tob/BTG1 homology domain (81% identity to Tob, 45% to BTG1, 42% to PC3, and 16% to ANA). Like Tob, Tob2 had a putative nuclear localization signal in the conserved domain. Fluorescence in situ hybridization (FISH) revealed that tob2 was located at human chromosome 22q13.1-q13.31 (Figure 2 ). Although there are reports showing loss of heterozygosity of this region in particular tumors (Iida et al., 1998) , further analysis is needed to establish involvement of tob2 in tumor formation.
Expression and subcellular localization of Tob2
Expression of human tob2 mRNA was assessed by Northern analysis of multiple tissue blots. As shown in Figure 3a , the 4.1-kb tob2 mRNA was ubiquitously expressed throughout the tissues tested, being relatively high in skeletal muscle, thymus, and ovary. Similar results were obtained using murine mRNAs (data not shown). Expression of tob2 was further analysed by in situ hybridization in several mouse tissues where the tob2 mRNA was relatively abundant. Clear, intense hybridization signals were found in ovary (Figure 3b) , showing characteristic expression of the tob2 mRNA in oocytes. Expression of tob2 was relatively weak in surrounding granulosa cells and in stroma cells. Therefore, Tob2 may be involved in a meiotic event during oogenesis. In the skeletal muscle and thymus, hybridization signals were distributed evenly throughout tissues (data not shown).
To analyse expression of the Tob2 protein, polyclonal antibodies against the amino-terminal 158 amino acids of the protein were prepared. 
Inhibition of G1 progression by exogenously expressed Tob2
To examine whether Tob2 was able to suppress cell proliferation similarly to the other family members, we microinjected the pME-Tob2 expression plasmid into serum-starved NIH3T3 cells. After the cells were re-fed with serum, Tob2 expressing cells were identi®ed by immunostaining with anti-Tob2 antibodies, and the cells that entered the S phase were identi®ed by reactivity to the anti-BrdU antibody. While 238 of 250 (95.2%) cells microinjected with a plasmid containing the b-galactosidase cDNA incorporated BrdU, only 44 of 159 (27.7%) cells expressing exogenous Tob2 showed BrdU incorporation (P50.05). Typical data are presented in Figure 5 . The data suggest that Tob2 inhibits cell cycle progression through the G1 phase.
To further demonstrate that Tob2 is able to suppress the cell growth in a manner dependent on cell cycle, we microinjected the Tob2 expression plasmid into the cells synchronized at the S phase (14 h after release of serum starvation) as well as in the early G1 phase (2 h after release of serum starvation). Pilot data showed that no more than 30% of Tob2-expressing cells incorporated BrdU when microinjected at early G1. In contrast, almost all Tob2-expressing cells incorporated BrdU when microinjected at the S phase. Thus, Tob2 could not suppress cell growth once the cells entered the S phase, suggesting cell cycle-dependent suppression of cell growth by Tob2. 
Identi®cation of human Caf1 as a Tob2 associated molecule
To help establish the molecular mechanism by which Tob2 suppressed cell cycle progression, we searched for molecules that interacted with Tob2. To do so, we carried out yeast two-hybrid screening, using the DNA fragment corresponding to the amino-terminal 158 amino acids of Tob2 as a bait. By screening a HeLa cDNA library (5610 6 clones), we obtained 58 candidate clones. Sequence analysis of these clones revealed that six independent isolates encoded the same protein highly homologous to mCaf1, a mouse CCR4 associated factor. Nucleotide sequencing of these clones revealed that human homologue of mCaf1 (hCaf1) consisted of 285 amino acids with a calculated molecular weight of 32,723. The predicted amino acid sequence of hCaf1 was identical to that of mCaf1 (Draper and Denis, 1995) except for one amino acid substitution at position 282.
Association of hCaf1 with Tob2 and Tob in mammalian cells
Expression plasmids pME-Tob2 and pME-¯ag-Caf1, carrying full-length Tob2 and¯ag-tagged full-length hCaf1, respectively, were co-transfected into the 293T cells. The lysates of the transfectants were subjected to immunoprecipitation with the anti-¯ag antibody, and the precipitates were probed by immunoblotting with anti-Tob2 antibodies. As shown in Figure 6a , the antiTob2 antibodies detected the Tob2 protein in the antiag-hCaf1 immunoprecipitates. In the reciprocal coimmunoprecipitation experiment, the anti-¯ag antibody detected the hCaf1 protein in the anti-Tob2 immunoprecipitates (data not shown). In addition, we could coimmunoprecipitate endogenous Caf1 using anti-Tob2 antibodies from the lysates of NIH3T3 cells (data not shown). We also performed anity precipitation experiments using the GST-fused Tob2 (GST-Tob2N, containing amino-terminal 158 amino acids of Tob2). After incubating GST-Tob2N with the lysates of 293T cells transfected with pME-¯ag-Caf1, molecules interacting with GST-Tob2N were precipitated using glutathione-Sepharose. As shown in Figure 6b , hCaf1 was co-precipitated with GST-Tob2N. Thus, Tob2 interacts with hCaf1 at the amino-terminal proximal region in vitro. Similar sets of experiments using a Tob expression plasmid and GST-fused amino-terminal half of Tob revealed that Tob also interacted with hCaf1 ( Figure 6b and data not shown) . The results suggest that Tob/BTG1 family proteins interact with Caf1, since their corresponding amino-terminal regions are homologous to one another.
Association of Caf1 with cyclin dependent kinases
As CDKs play important roles in the regulation of cell cycle progression, we addressed the possibility that Tob2 suppresses cell growth by aecting the activities of CDK family members. To do so, we examined interaction between Tob2 and CDKs and that between hCaf1 and CDKs by co-immunoprecipitation experiments. Proteins in the lysates of pME-Tob2 or pMEag-Caf1 transfectants were ®rst immunoprecipitated with the anti-Tob2 or anti-¯ag antibodies, respectively, and the immunoprecipitates were blotted with antibodies against Cdk2, Cdk4, and Cdc2. Reciprocally, precipitates with the antibodies against the CDK family members were probed by immunoblotting with the anti-Tob2 antibodies or anti-¯ag antibody. While no interaction between Tob2 and CDKs was detected (data not shown), hCaf1 showed clear interaction with Cdk4 and Cdc2 (Figure 7) . A very low level of interaction was detected between hCaf1 and Cdk2 ( Figure 7 ) and Cdk6 (data not shown). To rule out the possibility that the¯ag peptide interacts with various proteins non-speci®cally, we performed co-immunoprecipitation experiments using the lysates of¯ag-Cbl-c (Kim et al., 1999) expressing cells. Although Cdk4 are expressed in the cells, we could not detect Cdk4 in the anti-¯ag immunoprecipitates (Figure 7c ). The data strongly argue against non-speci®c interaction of thē ag sequence. Taken together, we tentatively concluded that Tob2 and other Tob/BTG1 family members are involved in cell cycle regulation by modulating CDK activities through their interaction with Caf1.
Discussion
In this study we cloned and characterized a novel member of the tob/BTG1 anti-proliferative gene family. The gene was named tob2 because of the high similarity of the gene product (Tob2) with the Tob protein. Tob and Tob2 are similar in size and therefore form a subgroup among the family members. However, homology between the two proteins is limited to the amino-terminal region of about 120 amino acids termed Tob/BTG1 homology domain, suggesting the functional importance of the domain. The rest of the As expected from the observation that the Tob/BTG1 homology domain is relevant to growth inhibition (Yoshida et al., 1998) , Tob2 showed anti-proliferative activity when overexpressed. The mechanism by which the Tob/BTG1 family proteins inhibit cell growth is not clear. BTG1 and PC3 reportedly interact with protein-arginine N-methyltransferase and are implicated in regulation of the activities of RNA binding proteins through methylation (Tang et al., 1998) . However, the relevance of the interaction to growth inhibition is not clear. Our current results show that Tob2 as well as Tob binds to Caf1 at the amino-terminal sequence of 158 amino acids that includes the Tob/BTG1 homology domain.
This suggests that Caf1 is relevant to the antiproliferative activity. If it is the case, then Caf1 may as well interact with other Tob/BTG1 family proteins. Indeed, two groups recently reported that BTG1 and PC3 interacted with Caf1 (Rouault et al., 1998; Bogdan et al., 1998) . The 20-amino-acid sequence termed region B in the Tob/BTG1 homology domain was important for the interaction.
As Caf1 is a component of a transcription machinery, interaction of Caf1 with Tob/BTG1 family proteins may aect expression of the genes involved in cell growth regulation. Moreover, we showed here that Caf1 intriguingly interacted with several CDKs. The data led us to hypothesize a mechanism of Tob/BTG1 family-mediated growth suppression; Tob/BTG1 family proteins could modulate the CDK activity by forming 1 and 3) or the carboxy-terminal proline-rich region (lanes 2 and 4) were immunoprecipitated with the anti-¯ag antibody. The immunocomplexes (lanes 1 and 2) and whole cell lysates (lanes 3 and 4) were subjected to immunoblotting using mouse anti-Cdk4 antibodies (Santa Cruz) and a possible transcription factor NOT in addition to CCR4 and Caf1 (Liu et al., 1997 (Liu et al., , 1998 . Because Dbf2 is involved in cell cycle progression, it would be interesting to examine whether the Dbf2 kinase can phosphorylate Tob/BTG1 family proteins and/or Caf1 protein. Taken together, Tob/BTG1 family proteins could form a large protein complex that includes CCR4 associated proteins as well as CDK family proteins. However, the mechanism of such a complex formation is not simple, because Tob/BTG1 family proteins are mainly in the cytoplasm (Figure 4b ; Montagnoli et al., 1996; Yoshida et al., 1998) , whereas Caf1 and CDKs are both localized in the nucleus. Subcellular distribution of these proteins may be regulated in a cell-cycle-dependent manner, allowing a complex formation in a restricted condition. Alternatively, Tob/BTG1 family protein would sequester Caf1 in the cytoplasm, thereby preventing interaction of Caf1 with CDKs. Without Caf1 association, CDKs may not function properly in vivo.
Another line of evidence from yeast genetics suggest that Caf1 is involved in DNA repair, as deletion and point mutation of caf1 suppress a mutant allele of the rad52 gene (Schild, 1995) , which is relevant to the recombinational repair of DNA damage and to mitotic and meiotic recombination. The Rad52 protein encoded by the mutant allele is defective in its interaction with Rad51, a functional homologue of bacterial RecA. Although inactivation of Caf1 restores the interaction between Rad51 and the mutant Rad52 protein, the underlying mechanism is not clear. Nevertheless, the ®nding that Caf1 is functionally relevant to the DNA repair system is intriguing and could provide us a clue to exploring the biological signi®cance of the interaction between Caf1 and CDKs and/or that of the interaction between Caf1 and the Tob/BTG1 family proteins.
Accumulating evidence has revealed that each member of the Tob/BTG1 family plays developmental roles in several tissues. For instance, the BTG1 mRNA increases rapidly after follicle-stimulating hormone stimulation and expresses stage-speci®city in rat testis (Raburn et al., 1995) , suggesting the possible involvement of BTG1 in spermatogenesis. Expression of the ANA mRNA in embryonic cartilages suggests that ANA plays a role in the proliferation and/or chondrocrytic dierentiation of the cartilage cells (Yoshida et al., 1998) . In our unpublished study with tob de®cient mice, we ®nd that Tob is involved in bone formation. Abundant expression of BTG2 in atrophic and preatrophic glands of the prostate implicates BTG2 in the dierentiation of prostate cells (Walden et al., 1998) . As Tob2 expression is relatively ubiquitous (Figure 3 ), Tob2 may play roles in the development of various tissues. Since the expression pattern of Tob2 is more or less similar to that of Tob and since the two proteins are quite similar in structure, they may be regulating cell growth by complementing each other. It should be noted that Tob2 might be involved in not only mitosis but also meiosis during oogenesis because the tob2 mRNA is expressed characteristically in oocytes. Expression of the tob mRNA is also seen in oocytes albeit less abundantly than that of tob2. The importance of Tob and Tob2 may become clear after further analyses that include gene knock-out experiments.
Materials and methods

Isolation of tob2 cDNA
Based on the conserved amino acid sequences WFPEKP and WVDPYE, oligonucleotide primers were synthesized, corresponding to a sense nucleotide sequence CATGAATTCA(T/ C)TGGT(A/T)(T/C)CCNGA-(A/G)AA(A/G)C and an antisense nucleotide sequence CACAGAATTCT-C(A/G)(A/ T)ANGG(A/G)TCNA(T/C)CCA, respectively. Using these primers and total RNAs isolated from the FL18 cell line, tobrelated cDNAs were RT ± PCR ampli®ed. The procedures of the ampli®cation and subsequent characterization of the ampli®ed cDNAs were as described (Yoshida et al., 1998) .
Northern blot
The human adult tissues membranes blotted with poly(A) + RNA (2.0 mg) were purchased from Clontech and were hybridized with tob2 cDNA fragment (nucleotides 1 ± 662) labeled with a- 
In situ hybridization
Various tissues were collected and ®xed in 4% paraformaldehyde, cryoprotected in 20% sucrose, embedded in OCT (Tissue-Tek, Miles Inc.) and stored at 7808C. Sections (14 mm) were cut on a cryostat, and were hybridized with riboprobes labeled with a-35 S-UTP as described (Umemori et al., 1992) . The pBluescript plasmid containing the mouse tob2 cDNA corresponding to the human tob2 cDNA (corresponding nucleotides 94 ± 647) was linearized with EcoRI or BamHI, and sense or antisense transcripts were produced using either T3 or T7 polymerase, respectively. Specimens were photographed by double exposure using dark illumination with a red ®lter and Hoechst epi¯uorescence optics.
Construction of plasmids
The tob2 cDNA corresponding to the coding region (nucleotides 84 ± 1204) was cloned into pME18S vector (Shiio et al., 1992) . The resultant plasmid was termed pME-Tob2 and used for transfection experiments. The cDNA for an N-terminal half of tob2 (nucleotides 84 ± 570) was cloned into pGEX vector (Pharmacia) to produce pGEX-Tob2N plasmid, and was used for production of the N-terminal half of Tob2 (amino acids 1 ± 158) protein fused at its N-terminus to a glutathione S-transferase (GST). The same cDNA was cloned into pGBT9 vector, and the resultant plasmid termed pGBT9-Tob2N was used for yeast-two hybrid screening. The cDNA for the full-length human caf1 was cloned into¯ag-tagged pME18S vector and pGEX vector to yield plasmid pME-Caf1 and pGEX-Caf1, respectively.
Chromosome mapping
Chromosomal localization of the human tob2 gene was performed by¯uorescence in situ hybridization (FISH) as described (Hirai et al., 1996) . In brief, the biotinylated cDNA probe for tob2 (1.4-kb) was hybridized to G-banded chromosomes on slides prepared from PHA-stimulated lymphocytes of normal donors. After overnight hybridization, the slides were washed and hybridization signals were detected using rabbit anti-biotin (ENZO),¯uorescein-labeled goat anti-rabbit IgG (ENZO), and Cy2-labeled donkey antigoat IgG (Amersham). The chromosomes were counterstained with propidium iodide.
Production of anti-Tob2 antibodies
A male New Zealand White rabbit was immunized with the N-terminal half of the Tob2 (amino acids 1 ± 158) protein fused at its N-terminus to GST (GST-Tob2N). The antibodies were puri®ed from sera of the immunized rabbit by anity chromatography, using at ®rst a column of NHSactivated Sepharose 4B resin (Pharmacia) conjugated to the GST protein (to subtract IgGs against the GST protein). The eluted volume was loaded through another column of NHSactivated Sepharose 4B resin conjugated to the GST-Tob2N protein.
Transfection and immuno¯uorescence microscopy
Human 293T cells were maintained in Dulbecco's modi®ed Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) at 378C in 5% CO 2 . For immunostaining, 293T cells were plated onto cover slides. The pME-Tob2 plasmids were transfected into 293T cells using the standard calcium phosphate method. The cells were ®xed with 4% (w/v) paraformaldehyde in phosphate buered saline (PBS), and permeabilized with 0.2% (w/v) Triton X-100 in PBS. The permeabilized cells were treated with 2% (w/v) bovine serum albumin (BSA; fraction V from Sigma) in PBS, and were incubated with anti-Tob2 antibodies in 2% (w/v) BSA at room temperature. After extensive wash with PBS, the cells were incubated with FITC-labeled goat anti-rabbit IgG (Southern Biotechnology Associates, Inc.) and DAPI (Boehringer Mannheim), and then washed with PBS.
Yeast two-hybrid screening
The yeast two-hybrid screening was performed using the fragment of amino-terminal 158-amino acids encoded by pGBT9-Tob2N as a bait. A yeast strain Y190 (Durfee et al., 1993 , Harper et al., 1993 carrying the pGBT9-Tob2N was transfected with a HeLa cDNA library fused with the GAL4 activation domain. Plasmid DNAs from positive clones were recovered in MH4 bacterial strain, and subjected to DNA sequence analysis using Takara Bcabest Sequence Kit (Takara). To test the speci®city of interactions with Tob2, cloned plasmids were reintroduced into Y190 strains containing either pGBT9-Tob2N or pGBT9-Lamin.
Immunoprecipitation and anity precipitation
For immunoprecipitation, indicated plasmids were transfected into 293T cells. Forty hours post-transfection, cells were washed with PBS, and then lysed with RIPA buer (50 mM HEPES pH 7.4, 1% Triton X-100, 0.5 mM deoxycholic acid, 10 mM NaPPi, 100 mM NaF, 4 mM EDTA, 1 mM PMSF, 50 unit/ml trasylol) or TNE buer (50 mM Tris-HCl pH 8.0, 1% NP-40, 20 mM EDTA, 1 mM PMSF, 50 unit/ml trasylol). The lysates were clari®ed by centrifugation and incubated with antibodies indicated. The immunocomplexes were precipitated and washed with RIPA buer or TNE buer. The immunoprecipitates were resolved by SDS ± PAGE and electroblotted onto nitrocellulose ®lters. The ®lters were then incubated with the anti-Tob -Tob2, -¯ag or -CDKs antibodies and followed by incubation with HRP-conjugated donkey anti-rabbit IgG or sheep anti-mouse IgG antibodies (Amersham). Rabbit anti-Tob and anti-Tob2 antibodies were produced in our laboratory (Matsuda et al., 1996 and as described above). Mouse anti-¯ag antibody (M2) was purchased from Kodak, and mouse anti-Cdc2, rabbit anti-Cdk2 and Cdk4 antibodies were from Santa Cruz. For anity precipitation, lysates of pME-Caf1-transfected 293T cells were incubated with the GST, GST-Tob2N or GSTTobN (amino acids 1 ± 168) protein (1.0 mg each) immobilized on glutathione-Sepharose beads. After washing with RIPA buer, the anity-bound proteins were resolved by SDS ± PAGE, electroblotted onto nitrocellulose, and then the blots were probed with anti-¯ag antibody.
Microinjection
NIH3T3 cells grown on coverslides (2610
4 cells/slide) were cultured in DMEM containing 0.1% calf serum for 24 h and then microinjected with pME-Tob2 or pME-b-gal (200 mg/ml DNA). After 24 h incubation, medium was replaced with fresh DMEM containing 10% calf serum and 50 ng/ml BrdU (Sigma). After incubation for another 18 h, cells were treated for staining with anti-Tob2 antibodies, anti-BrdU monoclonal antibody BU-4 (Takara), and DAPI as described (Baeg et al., 1995) .
